Optimization and biological evaluation of aminopyrimidine-based IκB kinase β inhibitors with potent anti-inflammatory effects
作者:Yongje Shin、Sang Min Lim、Hong Hua Yan、Sungwoo Jung、Zhenghuan Fang、Kyung Hee Jung、Soon-Sun Hong、Sungwoo Hong
DOI:10.1016/j.ejmech.2016.07.075
日期:2016.11
Targeting IκB kinase β (IKKβ) can be a promising strategy in the development of a therapeutic treatment of inflammatory diseases because IKKβ is well-recognized as a key mediator of the NF-κB signaling pathway. In this study, we have successfully developed a structure-activity relationship (SAR) profile of the aminopyrimidine-based IKKβ inhibitors through the structure-based design strategy to improve
靶向IκB激酶β(IKKβ)在炎症性疾病的治疗方法开发中可能是一个有前途的策略,因为IKKβ被公认为是NF-κB信号传导途径的关键介体。在这项研究中,我们已经通过基于结构的设计策略成功开发了基于氨基嘧啶的IKKβ抑制剂的结构-活性关系(SAR)谱,以改善抗炎作用的理化特性和细胞活性。代表性化合物通过抑制诱导型一氧化氮合酶(iNOS)的合成,在减少一氧化氮(NO)方面显示出所需的活性,并强烈抑制促炎性细胞因子(IL-1α,IL-6和TNF-α)的表达。8e的抑制作用 NF-κB途径的磷酸化作用进一步证实,NF-κB信号通路的抑制诱导了LPS刺激的Raw 264.7细胞的抗炎作用。